Next Article in Journal
Issues and Controversies in the Evolution of Oral Rehydration Therapy (ORT)
Next Article in Special Issue
Efforts to Identify and Combat Antimicrobial Resistance in Uganda: A Systematic Review
Previous Article in Journal
Licensed and Recommended Inactivated Oral CholeraVaccines: From Development to Innovative Deployment
Previous Article in Special Issue
Travel-Related Antimicrobial Resistance: A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
TropicalMed
Volume 6
Issue 1
10.3390/tropicalmed6010033
tropicalmed-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Emergence, Persistence, and Dissemination of Antimicrobial-Resistant Bacteria in Environmental Hajj Settings and Implications for Public Health

by
Jaffar A. Al-Tawfiq
1,2,3 and
Ziad A. Memish
4,5,6,*
1
Specialty Internal Medicine and Quality Division, Johns Hopkins Aramco Healthcare, Dhahran 31311, Saudi Arabia
2
Infectious Disease Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
3
Infectious Disease Division, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21093, USA
4
Director Research and Innovation Center, King Saud Medical City, Ministry of Health, Riyadh 12746, Saudi Arabia
5
Al-Faisal University, Riyadh 11533, Saudi Arabia
6
Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
*
Author to whom correspondence should be addressed.
Trop. Med. Infect. Dis. 2021, 6(1), 33; https://0-doi-org.brum.beds.ac.uk/10.3390/tropicalmed6010033
Submission received: 25 February 2021 / Revised: 5 March 2021 / Accepted: 8 March 2021 / Published: 10 March 2021
(This article belongs to the Special Issue Persistence of Antimicrobial Resistance in the Environment and Implications for Global Public Health)
Browse Figure
Versions Notes

Abstract

:
The emergence of antimicrobial resistance is causing the loss of what was once considered the miracle cure. The transmission of antimicrobial resistance during mass gathering is a potential threat in addition to other infectious diseases. Here, we review the English language literature on the rate and the acquisition of antimicrobial resistance during the Hajj. There is a variable incidence of methicillin-resistant Staphylococcus aureus, Escherichia coli, and Enterobacteriaceae. There had been no report of multi-drug-resistant Mycobacterium tuberculosis. Continued surveillance of antimicrobial resistance coupled with public health measures are needed to decrease the rate of emergence of resistance.

1. Introduction

It is known that there is an increasing trend in antimicrobial resistance among Gram-negative and Gram-positive bacteria. In a systematic review, the prevalence of findings, the prevalence of vancomycin-resistant Enterococcus faecium is high in the Eastern Mediterranean countries [1]. Another study showed increasing antimicrobial resistance among Acinetobacter baumannii globally as well [2]. The issue of antimicrobial resistance might be even exaggerated in the setting of mass gatherings such as the annual Hajj. There is also an increase in antimicrobial-resistant bacteria in the Kingdom of Saudi Arabia [3].
The annual Muslim Pilgrimage, Hajj, and the mini-Hajj, Umrah, are recurrent mass gathering events that take place annually in Makkah, Kingdom of Saudi Arabia (KSA). The annual Hajj is one of the largest recurrent mass gatherings (MGs) and accommodates two to three million Muslims who come from > 180 countries around the world [4,5]. This annual Hajj is considered one of five pillars of Islam and is a mandatory to be performed by able and capable adult Muslims once in a lifetime. However, Umrah is a shorter version of the Hajj and can be done optionally at any time during the year, whereas the Hajj has to be done in a specified period time in relation to the Lunar, Islamic, Calendar [5,6,7]. The estimated annual pilgrimage for both Hajj and Umrah is more than 10 million pilgrims [8]. The number of the annual Hajj pilgrims per year has increased from 1996 till 2012 when the grand mosque expansion project was started (Figure 1). The number of pilgrims decreased significantly during the COVID-19 pandemic.
The Kingdom of Saudi Arabia, through its Ministry of Health, has provided curative and preventative medical services to all pilgrims through the establishment of several hospitals and clinics in the Hajj premises. One of its many mandates is to control any potential spread of infectious diseases during the Hajj [8,9,10,11,12]. Prior to each Hajj season, the Saudi Ministry of Health coordinates with pertinent health authorities in the countries of origin of the pilgrims to develop suitable material for education and update on Hajj medical requirements [9].
Mass gathering events are associated with increased risk of transmission of infectious diseases especially respiratory tract infections [5,7,13,14,15,16]. Multiple reasons had been identified as risk factors for such occurrences and include attendance of a large number of pilgrims in congested overcrowded areas among many others. The repeated emergence of novel viral pathogens have always been feared with the recent emergence of pH1N1 in 2009, Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in 2012, and the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in 2020 [8,10,16,17,18,19].
The occurrence of diarrheal illnesses among attendees of mass gatherings is well established and continues to be included in the surveillance program during the Hajj [9,12,20,21,22]. The reported rates of diarrhea among pilgrims range from 1.1% to 23.3% in multiple cohort studies of 262,999 pilgrims from 2002 to 2013 [20].
Diarrheal illness among Hajj pilgrimage is another area of concern as it might be caused by antimicrobial-resistant organisms with the potential to spread during the mass gathering event. In one study, the most frequently associated pathogens in patients with diarrhea during the Hajj were: Salmonella spp., Shigella, enteroinvasive Escherichia coli (EIEC) and enterotoxigenic Escherichia coli (ETEC) [23]. In a systematic review of 15 studies of 262,999 pilgrims from 2002 to 2013 showed that the prevalence of diarrheal illness among pilgrimage was 2.3% (range: 1.1–23.3%) [21]. Cited risk factors for diarrhea among pilgrimage were: eating in restaurants [24] and being male [25,26], however, the source of food and eating raw vegetables were not associated significantly with the occurrence of diarrhea [25]. Diarrheal illness was reported among 12% of attendees in the annual Arbaeen mass gatherings in Iraq [27] and among 4.5% among attendees of the 2015 Grand Magal [28] in one study, and 14.5% had gastrointestinal symptoms in another study [29].

2. Antimicrobial-Resistant Bacteria among Diarrheal Pathogens

In one study, 40% of Salmonella and E. coli-diarrheal pathogens were extended-spectrum β-lactamases (ESBLs) and carbapenemases such as blaCTX-M-15 and blaNDM elements [23]. This high rate is alarming giving the fact that the Hajj pilgrimage attracts > 2 million pilgrims from 188 countries [22]. In another study, 2 of 267 rectal swabs were positive for Salmonella Newport serotype and these were resistant to multiple antibiotics (cephalosporins, gentamicin and colistin) and had bla(CTX-M-2) gene and had colistin resistance [30].

3. Antimicrobial-Resistant Bacteria among Enterobacteriaceae

Resistance to third generation cephalosporins was reported among 19–94% of E. coli and K. [31,32,33,34]. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae was found among pilgrims and multiple isolates had CTX-M type ESBL genes [30,35]. Another study of urinary E. coli isolates in pilgrims showed the presence of E. coli ST131 and ST648 [36]. One study of French pilgrims showed one E. coli isolate with blaNDM-5, blaCTX-M-15, blaTEM-1, and aadA2 (ST2659 and ST181) genes [37]. The presence of the mcr-1 plasmid mediating colistin resistance was found at a rate of 9% [38]. ESBL genes, blaCTX-M, blaTEM, and blaSHV, were reported in two studies conducted in ICU patients. The proportion of blaCTX-M and blaTEM in E. coli and K. pneumoniae cases was 18.5–30%, blaSHV was 7.4% and 17.2% among E. coli and K. pneumoniae, respectively [39,40]. The rate of imipenem-resistance among E. coli and K. pneumoniae was 4–11.9% [31,34,41]. For carbapenem-resistant P. aeruginosa isolated from patients, 4.1–18.4% carried blaVIM and 4.7–21.0% carried blaIMP [39,42,43]. Shiga toxin-producing E. coli among diarrheal isolates showed 70% resistance to trimethoprim-sulfamethoxazole [44]. A number of studies showed different extended-spectrum-β-lactamase (bla) genes that had been identified in the Hajj [23,35,36,37,45,46] (Table 1).

4. Antimicrobial Resistance among Acinetobacter baumannii and P. aeruginosa

The rate of imipenem-resistance among A. baumannii and P. aeruginosa was 4–60.5% and 4–43%, respectively. The prevalence of blaOXA-23 was 91% among A. baumannii causing infection in ICU patients [39]. The occurrence of metallo-β-lactamase genes among carbapenem-resistant A. baumannii isolates was 11.5–27.1% for blaVIM and 13.6% for blaIMP. [39,42,43]. In a study of French pilgrims, the rate of isolation of ceftriaxone-resistant A. baumannii with blaOXA-51-like gene was 14.4% throat, 25.6% rectal, and 3.3% from throat and rectal swabs [37]. The study was showed one A. baumannii isolate with imipenem resistance and had blaOXA-72 carbapenemase gene [37].

5. Occurrence of Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant S. aureus (VRSA)

The incidence of methicillin-resistant Staphylococcus aureus (MRSA) in isolates from patients during the Hajj had steadily increased overtime in parallel with the incidence in the community and the healthcare settings [47]. MRSA incidence was 2–7% in pilgrims in 2000–2004 [48], 28% in patients with sinusitis in 2014 [49] and 63% in community acquired infections in 2015 [50]. The rate of MRSA was 15–20% in Hajj pilgrimages and 10–11% in Umrah pilgrims and the rate was similar before and after participating in the events [51]. The incidence of MRSA among food handlers in Makkah was 0% in 2001–2002 and was 20% in 2014 [52,53]. Occurrence of vancomycin-resistant S. aureus (VRSA) was 2% among pilgrims [54]. The specific resistance gene was investigated among S. aureus isolates and these studies showed the presence of Panton-Valentine leucocidin (PVL) in 0–19% [55,56]. The presence of the fibronectin binding protein (fnBPA)-encoding gene in MRSA was 8% [55]. A summary of studies examining the occurrence of Methicillin-Resistant Staphylococcus aureus in the Hajj pilgrims and workers is shown in Table 2 [33,41,48,49,50,51,52,53,54,55,56,57,58].

6. Resistance among Other Gram-Positive Organisms

Resistance to vancomycin among Enterococcus faecalis was 3.5% and 2% for Enterococci [54]. Oxacillin-resistant coagulase-negative staphylococci (CoNS) rate was 61% in 2004–2005, 82.4% in 2008–2009, and 93.6% in 2012–2013 [41,54,59].

7. Occurrence of Antibiotic-Resistant Respiratory Bacterial Pathogens among Pilgrimages

In a study of the carriage of Streptococcus pneumoniae among pilgrims showed that 23% of such isolates were resistant to multiple antibiotics (≥3 classes of antibiotics) [60] with a rate of 21% for ampicillin-resistant S. pneumoniae [54]. In the same cohort study among 110 isolates from pilgrims, S. pneumoniae resistance was as follows: 30.9% were penicillin non-susceptible, 2.7% were intermediately resistant to amoxicillin and 1.8% were intermediately resistant to cefotaxime, 24.5% were resistant to erythromycin, 12.7% were resistant to clindamycin, 55.5% were resistant to tetracycline, 6.4% were resistant to chloramphenicol, 48.2% were resistant to trimethoprim-sulfamethoxazole, and 16.4% were intermediately resistant to trimethoprim-sulfamethoxazole [60].

8. Tuberculosis and the Hajj

Due to the crowding conditions and the fact that 50% of pilgrims arrive from places with high prevalence of tuberculosis, including Africa, Bangladesh, India, Pakistan and Southeast Asia [61]. The occurrence of pulmonary tuberculosis had been described among pilgrims. However, the data regarding drug resistance are sparse. The prevalence of active pulmonary tuberculosis is variable (1.2–10%) among hospitalized patients [61,62,63,64,65] (Table 3). One study of 1063 pilgrims showed that 15 (1.4%) had pulmonary tuberculosis and there was no multidrug-resistant cases [66]. However, there had been no description of any outbreak of tuberculosis related to the Hajj.

9. Transmission of Meningococcal Disease

Neisseria meningitidis is one of the most studied organisms when it comes to the Hajj and pilgrimage and it was associated with multiple outbreaks [11,67,68,69,70,71,72,73]. There had been two major outbreaks of N. meningitides in relation to the 1987 Hajj and the 2000–2001 [11,67,68,69]. Asymptomatic N. meningitidis was >80% and had a significant impact on the Hajj outbreaks during Hajj in 1987 and 2000–2001 [69,74]. In a recent study of 628 paired cohort pilgrims, the rate of acquisition of N. meningitidis was 5.7% on arrival and 2.5% on departure [68]. The outbreak in 1987 was caused by N. meningitidis serogroup A [74,75,76], and serogroup W135 [77]. The outbreaks in 2000–2001 were also associated with resistance to trimethoprim-sulfamethoxazole, sulfadiazine, cloxacillin and tetracycline [78]. Following the first outbreak the bivalent A and B meningococcal vaccine became mandatory and the quadrivalent (ACYW135) vaccine became mandatory after the second outbreak. The occurrence of azithromycin resistance among pilgrims was 8.3% and 10.3% before and after Hajj pilgrimage and 5% for ciprofloxacin [51]. Another study showed resistance among N. meningitides was as follows 5% to ciprofloxacin, 12% to ceftriaxone, 3% to rifampicin, and 9% to azithromycin [79].

10. Other Resistant Pathogens

The prevalence of resistance among Helicobacter pylori was 31% for metronidazole and 3% for tetracycline and erythromycin [80].

11. Discussion

It had been shown that mass gatherings such as the Hajj are significant pools for the spread and transmission of antimicrobial-resistant bacteria due to crowded conditions, droplet transmission, and lack of efficient personal hygiene [21]. There had been an increased rates of AMR in the Hajj pilgrims. The occurrence of plasmid-mediated resistance among bacteria may suggest that these bacteria may be transmitted across different pilgrims. It was shown that the spread of clones and specific AMR genes are associated with travel and food [81]. The detection of these AMR in pilgrims may provide an area for further research and investigation of ways of transmissions especially that the Hajj time changes overtime and falls in the summer season every 10 years [82].
Meningococcal disease continues to be a potential public risk at the Hajj due to the invasiveness of the disease, increasing antimicrobial resistance, diverse serotypes (A, C, W-135, Y, and others), changes in the incidence, and alterations in serogroups and genotypes [83]. Colonization by N. meningitidis can be a major potential source of infection and is a potential source of the spread to other parts of the world [9,60,84,85]. There had been several studies examining the rate of N. meningitidis and the rate was variable from 0% to 6.3% [86,87,88]. One study of a paired cohort showed a prevalence of N. meningitidis of 2.5% on arrival and 1.3% on departure [87,88]. Another paired cohort study showed a prevalence of 2.5% on arrival and 0.15% upon departure to have N. meningitidis [68]. A third cohort study showed rates of 0.3% and 0.6% of N. meningitides among paired cohort and non-paired cohort, respectively [89]. Another cohort French study showed 0% of N. meningitides on arrival and departure [90]. Ciprofloxacin prophylaxis had shown to decrease N. meningitidis carriage as follows: no ciprofloxacin group had 5.2% before and 4.6% after pilgrimage (P = 0.65) and with ciprofloxacin the rate was 8.1% and 0% before and after pilgrimage [91]. Mandatory ciprofloxacin prophylaxis is given to pilgrims arriving from Sub-Saharan African meningitis belt countries [10,74,92,93,94].
Use of antimicrobial agents without a prescription is a major drive to the development of antibiotic resistance and this is true in the case of the Hajj [95] and one study showed that 47.6% of pilgrims used antibiotics [96].
The main modes of transmission of antimicrobial-resistant bacteria are respiratory, direct contact, and food-borne. As such it is important to maintain a high level of infection control compliance among pilgrims and healthcare settings [97]. The profession of safe food is also very important. In addition, there is a need for fast and reliable diagnostic tests. The utilization of available vaccines would also contribute to the efforts to decrease transmission of antimicrobial-resistant organisms especially respiratory tract infections. There needs to be ongoing surveillance of bacterial and viral pathogens and the development of antimicrobial resistance among pilgrims utilizing electronic surveillance systems [9,98].
One important method to decrease the risk of antimicrobial-resistant organisms is vaccination that would decrease the risk of infection and thus the use of antimicrobial therapy. The Saudi ministry of health annually revise the recommendations for the utilization of vaccines during the Hajj [6,99]. These vaccines include the required and recommended vaccines. The rate of pneumococcal vaccination among pilgrims had been variable [18,60,89,90,100,101,102,103,104,105,106] (Table 4).
In addition, the Saudi authorities had banned the selling of antibiotics without a prescription. It is also important to continue the surveillance activities for the emergence of any antimicrobial-resistant organisms during the Hajj. The Saudi ministry of health had adopted electronic surveillance system [9]. The surveillance could be staged and may involve multiple methods such as syndromic and laboratory based surveillance [107]. The World Health Organization (WHO) had adopted the 5-4-8-4 approach to reduce the risk of antimicrobial resistance during the Hajj [108] and this could be applied to other mass gathering events as well. This approach included the five pillars of the WHO strategy that includes: increase awareness and surveillance, reduce infections, optimize antimicrobial use, and the development of an economic case for maintainable investment in antimicrobial resistance [109]. The next number, four, refers to the need to have clinicians adhere to the four moments of antibiotic prescribing strategy. This moment includes: the presence of bacterial infection requiring antibiotics, the need to order appropriate cultures and to initiate the appropriate empiric antibiotics, how long should antibiotics be prescribed, and when antibiotics could be stopped [110]. The number eight refers to the priority pathogens: Acinetobacter spp., E. coli, K. pneumoniae, N. gonorrhoeae, Salmonella spp., Shigella spp., S. aureus, S. pneumoniae. The last number refers to the four specimens to be collected for culture (blood, urine, stool, urethral and cervical swabs) [108].
The risk of tuberculosis among pilgrims is of particular importance. There had been no reported outbreaks of tuberculosis among pilgrims. However, the situation of pilgrims and the overcrowding conditions may promote the spread of respiratory pathogens such as tuberculosis and viral infections such as the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). For tuberculosis, it is assuring to note that the recent global burden of tuberculosis study estimates that there is a trend in the decline in the incidence of the disease and if such decline continues then a few countries may meet the Sustainable Development Goal (SDG) target to eliminate tuberculosis by 2030 [111]. The risk of the development of MERS-CoV was a real issue. However, a systematic review in 2018 showed no evidence of MERS-CoV among pilgrims [7]. A subsequent study of 28,197 returning pilgrims to Indonesia showed no evidence of MERS-CoV infection as well [112]. The emergence of SARS-CoV-2 and the subsequent development of the pandemic had attracted lots of attention towards the Hajj. Thus, the Kingdom of Saudi Arabia had taken multiple steps to prevent the introduction of the virus to the pilgrims. It was expected that the Hajj season in 2020 would be cancelled due to the pandemic [113]. Actually, Saudi Arabia suspended the Umrah (mini-Hajj) and limited the access to the 2020 Hajj [8]. With continued pandemic and decreasing cases in Saudi Arabia, the government had taken steps to ease the strictions and developed a staged approach to scaling up the Umrah Pilgrimage in the last few months of 2020 [114].
To control the increasing antimicrobial resistance globally, two important public health proposals are to include education and training of the medical students during undergraduate and post-graduate studies. For example, in one study, 81% of 1055 young physicians indicated that antimicrobial resistance was not adequately addressed during medical training [115]. This is further exemplified by a study of the knowledge, attitude and practice of healthcare workers deployed during two Hajj seasons, where 85% indicated hearing about antimicrobial resistance and 19% had heard about antimicrobial stewardship programs [116]. In addition, it is important to include education and training of the young physicians on the discipline of mass gathering to alert them to the medical risks and challenges [117].

Author Contributions

Both authors contributed equally to the manuscript and the review. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Shiadeh, S.M.J.; Pormohammad, A.; Hashemi, A.; Lak, P. Global prevalence of antibiotic resistance in blood-isolated enterococcus faecalis and enterococcus faecium: A systematic review and meta-analysis. Infect. Drug Resist. 2019, 12, 2713–2725. [Google Scholar] [CrossRef] [Green Version]
  2. Xie, R.; Zhang, X.D.; Zhao, Q.; Peng, B.; Zheng, J. Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries. Emerg. Microbes Infect. 2018, 7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Al-Tawfiq, J.A.; Rabaan, A.A.; Saunar, J.V.; Bazzi, A.M. Antimicrobial resistance of gram-negative bacteria: A six-year longitudinal study in a hospital in Saudi Arabia. J. Infect. Public Health 2020, 13, 737–745. [Google Scholar] [CrossRef]
  4. Memish, Z.A.; Steffen, R.; White, P.; Dar, O.; Azhar, E.I.; Sharma, A.; Zumla, A. Mass gatherings medicine: Public health issues arising from mass gathering religious and sporting events. Lancet 2019, 393, 2073–2084. [Google Scholar] [CrossRef]
  5. Al-Tawfiq, J.A.; Gautret, P.; Benkouiten, S.; Memish, Z.A. Mass Gatherings and the Spread of Respiratory Infections. Lessons from the Hajj. Ann. Am. Thorac. Soc. 2016, 13, 759–765. [Google Scholar] [CrossRef]
  6. Al-Tawfiq, J.A.; Gautret, P.; Memish, Z.A. Expected immunizations and health protection for Hajj and Umrah 2018—An overview. Travel Med. Infect. Dis. 2017, 19, 2–7. [Google Scholar] [CrossRef] [PubMed]
  7. Al-Tawfiq, J.A.; Benkouiten, S.; Memish, Z.A.; Memishc, Z.A. Systematic review of emerging respiratory viruses at the Hajj and possible coinfection with Streptococcus pneumoniae. Vaccine 2017, 23, 6–13. [Google Scholar] [CrossRef] [PubMed]
  8. Hoang, V.-T.; Gautret, P.; Memish, Z.A.; Al-Tawfiq, J.A. Hajj and Umrah Mass Gatherings and COVID-19 Infection. Curr. Trop. Med. Rep. 2020, 7, 133–140. [Google Scholar] [CrossRef]
  9. Memish, Z.A.; Zumla, A.; Alhakeem, R.F.; Assiri, A.; Turkestani, A.; Al Harby, K.D.; Alyemni, M.; Dhafar, K.; Gautret, P.; Barbeschi, M.; et al. Hajj: Infectious disease surveillance and control. Lancet 2014, 383, 2073–2082. [Google Scholar] [CrossRef]
  10. Al-Tawfiq, J.A.; Memish, Z.A. Mass gathering medicine: 2014 Hajj and Umra preparation as a leading example. Int. J. Infect. Dis. 2014, 27, 26–31. [Google Scholar] [CrossRef] [Green Version]
  11. Al-Tawfiq, J.A.; Memish, Z.A. Mass gatherings and infectious diseases: Prevention, detection, and control. Infect. Dis. Clin. N. Am. 2012, 26, 725–737. [Google Scholar] [CrossRef] [PubMed]
  12. Elachola, H.; Al-Tawfiq, J.A.; Turkestani, A.; Memish, Z.A. Public health emergency operations center—A critical component of mass gatherings management infrastructure. J. Infect. Dev. Ctries 2016, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Al-Tawfiq, J.A.; Smallwood, C.A.H.; Arbuthnott, K.G.; Malik, M.S.K.; Barbeschi, M.; Memish, Z.A. Emerging respiratory and novel coronavirus 2012 infections and mass gatherings. East Mediterr. Health J. 2013, 19 (Suppl. S1), S48–S54. [Google Scholar] [CrossRef]
  14. Benkouiten, S.; Al-Tawfiq, J.A.J.A.; Memish, Z.A.; Albarrak, A.; Gautret, P. Clinical respiratory infections and pneumonia during the Hajj pilgrimage: A systematic review. Travel Med. Infect. Dis. 2019, 28, 15–26. [Google Scholar] [CrossRef]
  15. Al-Tawfiq, J.A.J.A.; Zumla, A.; Memish, Z.A.Z.A. Respiratory tract infections during the annual Hajj: Potential risks and mitigation strategies. Curr. Opin. Pulm. Med. 2013, 19, 192–197. [Google Scholar] [CrossRef] [PubMed]
  16. Gautret, P.; Benkouiten, S.; Al-Tawfiq, J.A.; Memish, Z.A. Hajj-associated viral respiratory infections: A systematic review. Travel Med. Infect. Dis. 2016, 14, 92–109. [Google Scholar] [CrossRef]
  17. Al-Tawfiq, J.A.; Zumla, A.; Memish, Z.A. Travel implications of emerging coronaviruses: SARS and MERS-CoV. Travel Med. Infect. Dis. 2014, 12, 422–428. [Google Scholar] [CrossRef] [PubMed]
  18. Memish, Z.A.; Assiri, A.; Almasri, M.; Alhakeem, R.F.; Turkestani, A.; Al Rabeeah, A.A.; Al-Tawfiq, J.A.; Alzahrani, A.; Azhar, E.; Makhdoom, H.Q.; et al. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J. Infect. Dis. 2014, 210, 1067–1072. [Google Scholar] [CrossRef] [Green Version]
  19. Gautret, P.; Benkouiten, S.; Al-Tawfiq, J.A.; Memish, Z.A. The spectrum of respiratory pathogens among returning Hajj pilgrims: Myths and reality. Int. J. Infect. Dis. 2016, 47, 83–85. [Google Scholar] [CrossRef] [Green Version]
  20. Gautret, P.; Benkouiten, S.; Sridhar, S.; Al-Tawfiq, J.A.; Memish, Z.A. Diarrhea at the Hajj and Umrah. Travel Med. Infect. Dis. 2015, 13, 159–166. [Google Scholar] [CrossRef] [PubMed]
  21. Leangapichart, T.; Rolain, J.-M.; Memish, Z.A.; Al-Tawfiq, J.A.; Gautret, P. Emergence of drug resistant bacteria at the Hajj: A systematic review. Travel Med. Infect. Dis. 2017, 18, 3–17. [Google Scholar] [CrossRef] [Green Version]
  22. El Ghany, M.A.; Al-Tawfiq, J.A.; Hill-Cawthorne, G.A.; Memish, Z.A. Hajj-Beyond traveller’s diarrhea. Travel Med. Infect. Dis. 2017, 21, 80–81. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. El Ghany, M.A.; Alsomali, M.; Almasri, M.; Regalado, E.P.; Naeem, R.; Tukestani, A.; Asiri, A.; Hill-Cawthorne, G.A.; Pain, A.; Memish, Z.A. Enteric Infections Circulating during Hajj Seasons, 2011–2013. Emerg. Infect. Dis. 2017, 23, 1640–1649. [Google Scholar] [CrossRef] [Green Version]
  24. Maslamani, Y.A.M.; Choudhry, A.J. Health related experiences among international pilgrims departing through King Abdul Aziz international airport, Jeddah, Saudi Arabia, Hajj 1431 H [2010]. Saudi Epidemiol. Bull. 2011, 18, 42–44. [Google Scholar]
  25. Al-Jasser, F.S.; Kabbash, I.A.; Almazroa, M.A.; Memish, Z.A. Patterns of diseases and preventive measures among domestic hajjis from Central, Saudi Arabia. Saudi Med. J. 2012, 33, 879–886. [Google Scholar]
  26. Omar, S. Digestive Discomforts and Effect of Ingested Food in People Performing Hajj. J. Basic Appl. Sci. 2013, 16, 341–347. [Google Scholar] [CrossRef] [Green Version]
  27. Al-Ansari, F.; Al Ansari, M.; Hill-Cawthorne, G.A.; Abdulzahra, M.S.; Al-Ansari, M.B.; Al-Ansari, B.; Rashid, H.; Negin, J.; Conigrave, K.M. Arbaeen public health concerns: A pilot cross-sectional survey. Travel Med. Infect. Dis. 2020, 35. [Google Scholar] [CrossRef]
  28. Sokhna, C.; Mboup, B.M.; Sow, P.G.; Camara, G.; Dieng, M.; Sylla, M.; Gueye, L.; Sow, D.; Diallo, A.; Parola, P.; et al. Communicable and non-communicable disease risks at the Grand Magal of Touba: The largest mass gathering in Senegal. Travel Med. Infect. Dis. 2017, 19, 56–60. [Google Scholar] [CrossRef]
  29. Hoang, V.T.; Goumballa, N.; Dao, T.L.; Ly, T.D.A.; Ninove, L.; Ranque, S.; Raoult, D.; Parola, P.; Sokhna, C.; de Santi, V.P.; et al. Respiratory and gastrointestinal infections at the 2017 Grand Magal de Touba, Senegal: A prospective cohort survey. Travel Med. Infect. Dis. 2019, 32. [Google Scholar] [CrossRef]
  30. Olaitan, A.O.; Dia, N.M.; Gautret, P.; Benkouiten, S.; Belhouchat, K.; Drali, T.; Parola, P.; Brouqui, P.; Memish, Z.; Raoult, D.; et al. Acquisition of extended-spectrum cephalosporin- and colistin-resistant Salmonella enterica subsp. enterica serotype Newport by pilgrims during Hajj. Int. J. Antimicrob. Agents 2015, 45, 600–604. [Google Scholar] [CrossRef] [PubMed]
  31. Asghar, A.H.; Faidah, H.S. Frequency and antimicrobial susceptibility of gram-negative bacteria isolated from 2 hospitals in Makkah, Saudi Arabia. Saudi Med. J. 2009, 30, 1017–1023. [Google Scholar] [PubMed]
  32. Khan, M.A.; Mahomed, M.F.; Ashshi, A.M. Drug resistance patterns of Acinetobacter baumannii in Makkah, Saudi Arabia. Pak. J. Med. Res. 2012, 51, 127–131. [Google Scholar]
  33. Johargy, A.K. Antimicrobial susceptibility of bacterial and fungal infections among infected diabetic patients. J. Pak. Med. Assoc. 2016, 66, 1291–1295. [Google Scholar]
  34. Khan, M.M.A.; Faiz, A. Frequency of Carbapenemase Producing Klebsiella pneumoniae in Makkah, Saudi Arabia. J. Microbiol. Infect. Dis. 2016, 6, 121–127. [Google Scholar] [CrossRef]
  35. Leangapichart, T.; Dia, N.M.; Olaitan, A.O.; Gautret, P.; Brouqui, P.; Rolain, J.-M. Acquisition of Extended-Spectrum β-Lactamases by Escherichia coli and Klebsiella pneumoniae in Gut Microbiota of Pilgrims during the Hajj Pilgrimage of 2013. Antimicrob. Agents Chemother. 2016, 60, 3222–3226. [Google Scholar] [CrossRef] [Green Version]
  36. Alyamani, E.J.; Khiyami, A.M.; Booq, R.Y.; Majrashi, M.A.; Bahwerth, F.S.; Rechkina, E. The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia. Ann. Clin. Microbiol. Antimicrob. 2017, 16, 1. [Google Scholar] [CrossRef] [Green Version]
  37. Leangapichart, T.; Gautret, P.; Griffiths, K.; Belhouchat, K.; Memish, Z.; Raoult, D.; Rolain, J.-M. Acquisition of a High Diversity of Bacteria during the Hajj Pilgrimage, Including Acinetobacter baumannii with blaOXA-72 and Escherichia coli with blaNDM-5 Carbapenemase Genes. Antimicrob. Agents Chemother. 2016, 60, 5942–5948. [Google Scholar] [CrossRef] [Green Version]
  38. Leangapichart, T.; Gautret, P.; Brouqui, P.; Mimish, Z.; Raoult, D.; Rolain, J.-M. Acquisition of mcr-1 plasmid-mediated colistin resistance in Escherichia coli and Klebsiella pneumoniae during Hajj 2013 and 2014. Antimicrob. Agents Chemother. 2016, 60, 6998–6999. [Google Scholar] [CrossRef] [Green Version]
  39. Asghar, A.H. Antimicrobial Resistance of Gram-Negative Bacilli Causing Infections in Intensive Care Units in Makkah Hospitals-Saudi Arabia. J. Am. Sci. 2012, 8, 720–725. [Google Scholar]
  40. Alyamani, E.J.; Khiyami, M.A.; Booq, R.Y.; Alnafjan, B.M.; Altammami, M.A.; Bahwerth, F.S. Molecular characterization of extended-spectrum beta-lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia. Ann. Clin. Microbiol. Antimicrob. 2015, 14, 38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Asghar, A.H. Frequency and antimicrobial susceptibility patterns of bacterial pathogens isolated from septicemic patients in Makkah hospitals. Saudi Med. J. 2006, 27, 361–367. [Google Scholar] [PubMed]
  42. Asghar, A.H. Antimicrobial susceptibility and metallo-β-lactamase production among Pseudomonas aeruginosa isolated from Makkah hospitals. Pak. J. Med. Sci. 2012, 28, 7. [Google Scholar]
  43. El-Ageery, S.M.; Al-Hazmi, S.S. Microbiological and molecular detection of VIM-1 metallo-beta-lactamase-producing Acinetobacter baumannii. Eur. Rev. Med. Pharm. Sci. 2014, 18, 965–970. [Google Scholar]
  44. Sharaf, E.F.; Shabana, I.I. Prevalence and molecular characterization of Shiga toxin-producing Escherichia coli isolates from human and sheep in Al-Madinah Al-Munawarah. Infectio 2016. [Google Scholar] [CrossRef]
  45. Leangapichart, T.; Tissot-Dupont, H.; Raoult, D.; Memish, Z.A.; Rolain, J.-M.; Gautret, P. Risk factors for acquisition of CTX-M genes in pilgrims during Hajj 2013 and 2014. J. Antimicrob. Chemother. 2017, 72, 2627–2635. [Google Scholar] [CrossRef]
  46. Al-Zahrani, I.; Alasiri, B. The emergence of carbapenem-resistant Klebsiella pneumoniae isolates producing OXA-48 and NDM in the Southern (Asir) province, Saudi Arabia. Saudi Med. J. 2018, 39, 23–30. [Google Scholar] [CrossRef] [PubMed]
  47. Nazeer, A.; Al-Tawfiq, J.A. Methicillin-resistant Staphylococcus aureus metrics for patients in Saudi Arabia. J. Infect. Dev. Ctries 2012, 6, 223–233. [Google Scholar] [CrossRef] [Green Version]
  48. Fatani, M.I.; Bukhari, S.Z.; Al-Afif, K.A.; Karima, T.M.; Abdulghani, M.R.; Al-Kaltham, M.I. Pyoderma among Hajj Pilgrims in Makkah. Saudi Med. J. 2002, 23, 782–785. [Google Scholar]
  49. Marglani, O.A.; Alherabi, A.Z.; Herzallah, I.R.; Saati, F.A.; Tantawy, E.A.; Alandejani, T.A.; Faidah, H.S.; Bawazeer, N.A.; Marghalani, A.A.; Madani, T.A. Acute rhinosinusitis during Hajj season 2014: Prevalence of bacterial infection and patterns of antimicrobial susceptibility. Travel Med. Infect. Dis. 2016, 14, 583–587. [Google Scholar] [CrossRef]
  50. Haseeb, A.; Faidah, H.S.; Bakhsh, A.R.; Al Malki, W.H.; Elrggal, M.E.; Saleem, F.; Rahman, S.U.; Khan, T.M.; Hassali, M.A. Antimicrobial resistance among pilgrims: A retrospective study from two hospitals in Makkah, Saudi Arabia. Int. J. Infect. Dis. 2016, 47, 92–94. [Google Scholar] [CrossRef] [Green Version]
  51. Johargy, A.; Sorour, A.; Momenah, A. Prevalence of Nasal Carriage of Staphylococcus aureus among Umrah visitors and Pilgrims During Umrah and Hajj Seasons. Egypt J. Med. Microbiol. 2011, 20, 162–166. [Google Scholar]
  52. Dablool, A.; Al-Ghamdi, S. Enterotoxigenicity of Staphylococcus aureus isolated from food handlers during Hajj season in Saudi Arabia. Open J. Saf. Sci. 2011, 1, 75–78. [Google Scholar] [CrossRef] [Green Version]
  53. Ahmed, B.; Mashat, B.H. Prevalence of classical enterotoxin genes in Staphylococcus aureus isolated from food handlers in Makkah city kitchens. Asian J. Sci. Tech. 2014, 5, 727–731. [Google Scholar]
  54. Asghar, A.H. Frequency and antibiotic susceptibility of gram-positive bacteria in Makkah hospitals. Ann. Saudi Med. 2011, 31, 462–468. [Google Scholar] [CrossRef]
  55. Abulreesh, H.H.; Organji, S.R.; Osman, G.E.H.; Elbanna, K.; Almalki, M.H.K.; Ahmad, I. Prevalence of antibiotic resistance and virulence factors encoding genes in clinical Staphylococcus aureus isolates in Saudi Arabia. Clin. Epidemiol. Glob. Health 2016, 5, 196–202. [Google Scholar] [CrossRef] [Green Version]
  56. Asghar, A.H. Molecular characterization of methicillin-resistant Staphylococcus aureus isolated from tertiary care hospitals. Pak. J. Med. Sci. 2014, 30, 698–702. [Google Scholar] [CrossRef] [PubMed]
  57. Memish, Z.A.; Balkhy, H.H.; Almuneef, M.A.; Al-Haj-Hussein, B.T.; Bukhari, A.I.; Osoba, A.O. Carriage of Staphylococcus aureus among Hajj pilgrims. Saudi Med. J. 2006, 27, 1367–1372. [Google Scholar]
  58. Asghar, A.H.; Momenah, A.M. Methicillin resistance among Staphylococcus aureus isolates from Saudi Hospitals. Med. Princ. Pract. 2006, 15, 52–55. [Google Scholar] [CrossRef] [PubMed]
  59. Khan, M.M.A.; Faiz, A.; Ashshi, A.M. Clinically significant coagulase negative staphylococci and their antibiotic resistance pattern in a tertiary care hospital. J. Pak. Med. Assoc. 2014, 64, 1171–1174. [Google Scholar]
  60. Memish, Z.A.; Al-Tawfiq, J.A.; Almasri, M.; Akkad, N.; Yezli, S.; Turkestani, A.; van der Linden, M.; Assiri, A. A cohort study of the impact and acquisition of naspharyngeal carriage of Streptococcus pneumoniae during the Hajj. Travel Med. Infect. Dis. 2016, 14, 242–247. [Google Scholar] [CrossRef]
  61. Mandourah, Y.; Al-Radi, A.; Ocheltree, A.H.; Ocheltree, S.R.; Fowler, R.A. Clinical and temporal patterns of severe pneumonia causing critical illness during Hajj. BMC Infect. Dis. 2012, 12, 117. [Google Scholar] [CrossRef] [Green Version]
  62. Al-Orainey, I.O. Tuberculosis infection during Hajj pilgrimage. The risk to pilgrims and their communities. Saudi Med. J. 2013, 34, 676–680. [Google Scholar] [PubMed]
  63. Alzeer, A.; Mashlah, A.; Fakim, N.; Al-Sugair, N.; Al-Hedaithy, M.; Al-Majed, S.; Jamjoom, G. Tuberculosis is the commonest cause of pneumonia requiring hospitalization during Hajj (pilgrimage to Makkah). J. Infect. 1998, 36, 303–306. [Google Scholar] [CrossRef]
  64. Madani, T.A.; Ghabrah, T.M.; Al-Hedaithy, M.A.; Alhazmi, M.A.; Alazraqi, T.A.; Albarrak, A.M.; Ishaq, A.H. Causes of hospitalization of pilgrims in the Hajj season of the Islamic year 1423 (2003). Ann. Saudi Med. 2006, 26, 346–351. [Google Scholar] [CrossRef]
  65. El-Sheikh, S.M.; El-Assouli, S.M.; Mohammed, K.A.; Albar, M. Bacteria and viruses that cause respiratory tract infections during the pilgrimage (Haj) season in Makkah, Saudi Arabia. Trop. Med. Int. Health 1998, 3, 205–209. [Google Scholar] [PubMed]
  66. Yezli, S.; Zumla, A.; Yassin, Y.; Al-Shangiti, A.M.; Mohamed, G.; Turkistani, A.M.; Alotaibi, B. Undiagnosed active pulmonary tuberculosis among pilgrims during the 2015 Hajj mass gathering: A prospective cross-sectional study. Am. J. Trop. Med. Hyg. 2017, 97, 1304–1309. [Google Scholar] [CrossRef]
  67. Shafi, S.; Booy, R.; Haworth, E.; Rashid, H.; Memish, Z.A. Hajj: Health lessons for mass gatherings. J. Infect. Public Health 2008, 1, 27–32. [Google Scholar] [CrossRef]
  68. Memish, Z.A.; Al-Tawfiq, J.A.; Almasri, M.; Azhar, E.I.; Yasir, M.; Al-Saeed, M.S.; Ben Helaby, H.; Borrow, R.; Turkistani, A.; Assiri, A. Neisseria meningitidis nasopharyngeal carriage during the Hajj: A cohort study evaluating the need for ciprofloxacin prophylaxis. Vaccine 2017, 35, 2473–2478. [Google Scholar] [CrossRef] [Green Version]
  69. Al-Tawfiq, J.A.; Clark, T.A.; Memish, Z.A. Meningococcal disease: The organism, clinical presentation, and worldwide epidemiology. J. Travel Med. 2010, 17, 3–8. [Google Scholar] [CrossRef] [Green Version]
  70. Lucidarme, J.; Scott, K.J.; Ure, R.; Smith, A.; Lindsay, D.; Stenmark, B.; Jacobsson, S.; Fredlund, H.; Cameron, J.C.; Smith-Palmer, A.; et al. An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015. Eurosurveillance 2016, 21, 30395. [Google Scholar] [CrossRef]
  71. Wilder-Smith, A.; Goh, K.T.; Barkham, T.; Paton, N.I. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: Estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin. Infect. Dis. 2003, 36, 679–683. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Aguilera, J.-F.; Perrocheau, A.; Meffre, C.; Hahné, S.; W135 Working Group. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg. Infect. Dis. 2002, 8, 761–767. [Google Scholar] [CrossRef]
  73. Dull, P.M.; Abdelwahab, J.; Sacchi, C.T.; Becker, M.; Noble, C.A.; Barnett, G.A.; Kaiser, R.M.; Mayer, L.W.; Whitney, A.M.; Schmink, S.; et al. Neisseria meningitidis Serogroup W-135 Carriage among US Travelers to the 2001 Hajj. J. Infect. Dis. 2005, 191, 33–39. [Google Scholar] [CrossRef] [Green Version]
  74. Al-Gahtani, Y.M.; El Bushra, H.E.; Al-Qarawi, S.M.; Al-Zubaidi, A.A.; Fontaine, R.E. Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992. Epidemiol. Infect. 1995, 115, 399–409. [Google Scholar] [CrossRef] [Green Version]
  75. Moore, P.S.; Reeves, M.W.; Schwartz, B.; Gellin, B.G.; Broome, C.V. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet 1989, 2, 260–263. [Google Scholar] [CrossRef]
  76. Novelli, V.M.; Lewis, R.G.; Dawood, S.T. Epidemic group A meningococcal disease in Haj pilgrims. Lancet 1987, 2, 863. [Google Scholar] [CrossRef]
  77. Lingappa, J.R.; Al-Rabeah, A.M.; Hajjeh, R.; Mustafa, T.; Fatani, A.; Al-Bassam, T.; Badukhan, A.; Turkistani, A.; Makki, S.; Al-Hamdan, N.; et al. Serogroup W-135 Meningococcal Disease during the Hajj, 2000. Emerg. Infect. Dis. 2003, 9, 665–671. [Google Scholar] [CrossRef] [PubMed]
  78. Mölling, P.; Bäckman, A.; Olcén, P.; Fredlund, H. Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage. J. Clin. Microbiol. 2001, 39, 2695–2699. [Google Scholar] [CrossRef] [Green Version]
  79. Ashgar, S.S.; El-Said, H.M.; Johargy, A.; Momenah, A.M.; Asghar, A.; Sorour, A.E.; Alherabi, A.; Mashat, B.H.; Aalam, A. Prevalence of Nasal Carriage of Neisseria meningitidis among Umrah Visitors and Pilgrims during Umrah and Hajj Season. Glob. Adv. Res. J. Microbiol. 2013, 2, 141–149. [Google Scholar]
  80. Karima, T.M.; Bukhari, S.Z.; Ghais, M.A.; Fatani, M.I.; Hussain, W.M. Prevalence of Helicobacter pylori infection in patients with peptic ulcer diseases. Saudi Med. J. 2006, 27, 621–626. [Google Scholar]
  81. Fonteneau, L.; da Silva, N.J.; Fabre, L.; Ashton, P.; Torpdahl, M.; Müller, L.; Bouchrif, B.; El Boulani, A.; Valkanou, E.; Mattheus, W.; et al. Multinational outbreak of travel-related Salmonella Chester infections in Europe, summers 2014 and 2015. Eurosurveillance 2017, 22. [Google Scholar] [CrossRef] [Green Version]
  82. Aleeban, M.; Mackey, T.K. Global Health and Visa Policy Reform to Address Dangers of Hajj during Summer Seasons. Front. Public Health 2016, 4, 2–5. [Google Scholar] [CrossRef] [Green Version]
  83. Zumla, A.; Memish, Z.A. Risk of antibiotic resistant meningococcal infections in Hajj pilgrims. BMJ 2019, 366. [Google Scholar] [CrossRef]
  84. Korzeniewski, K.; Skoczyńska, A.; Guzek, A.; Konior, M.; Chciałowski, A.; Waśko, I.; Markowska, M.; Zwolińska, E. Effectiveness of Immunoprophylaxis in Suppressing Carriage of Neisseria meningitidis in the Military Environment. Adv. Exp. Med. Biol. 2014, 836, 19–28. [Google Scholar] [CrossRef]
  85. Stephens, D.S. Conquering the Meningococcus. FEMS Microbiol. Rev. 2007, 31, 3–14. [Google Scholar] [CrossRef] [Green Version]
  86. Husain, E.H.; Dashti, A.A.; Electricwala, Q.Y.; Abdulsamad, A.M.; Al-Sayegh, S. Absence of Neisseria meningitidis from throat swabs of Kuwaiti pilgrims after returning from the Hajj. Med. Princ. Pract. 2010, 19, 321–323. [Google Scholar] [CrossRef] [PubMed]
  87. Centers for Disease Control and Prevention (CDC). Risk for meningococcal disease associated with the Hajj 2001. MMWR Morb. Mortal. Wkly. Rep. 2001, 50, 97–98. [Google Scholar]
  88. Centers for Disease Control and Prevention (CDC). Update: Assessment of risk for meningococcal disease associated with the Hajj 2001. MMWR Morb. Mortal. Wkly. Rep. 2001, 50, 221–222. [Google Scholar]
  89. Memish, Z.A.; Assiri, A.; Turkestani, A.; Yezli, S.; Al Masri, M.; Charrel, R.; Drali, T.; Gaudart, J.; Edouard, S.; Parola, P.; et al. Mass gathering and globalization of respiratory pathogens during the 2013 Hajj. Clin. Microbiol. Infect. 2015, 21, 571.e8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  90. Benkouiten, S.; Charrel, R.; Belhouchat, K.; Drali, T.; Nougairede, A.; Salez, N.; Memish, Z.A.; Al Masri, M.; Fournier, P.-E.; Raoult, D.; et al. Respiratory viruses and bacteria among pilgrims during the 2013 Hajj. Emerg. Infect. Dis. 2014, 20, 1821–1827. [Google Scholar] [CrossRef]
  91. Alborzi, A.; Oskoee, S.; Pourabbas, B.; Alborzi, S.; Astaneh, B.; Gooya, M.M.; Kaviani, M.J. Meningococcal carrier rate before and after hajj pilgrimage: Effect of single dose ciprofloxacin on carriage. East Mediterr. Health J. 2008, 14, 277–282. [Google Scholar] [PubMed]
  92. Al-Tawfiq, J.A.; Memish, Z.A. The Hajj: Updated health hazards and current recommendations for 2012. Eurosurveillance 2012, 17, 20295. [Google Scholar] [PubMed]
  93. Memish, Z.A. Meningococcal Disease and Travel. Clin. Infect. Dis. 2002, 34, 84–90. [Google Scholar] [CrossRef] [Green Version]
  94. Shibl, A.; Tufenkeji, H.; Khalil, M.; Memish, Z.; Meningococcal Leadership Forum (MLF) Expert Group. Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine. East. Mediterr. Health J. 2013, 19, 389–392. [Google Scholar] [CrossRef]
  95. Qureshi, H.; Gessner, B.D.; Leboulleux, D.; Hasan, H.; Alam, S.E.; Moulton, L.H. The incidence of vaccine preventable influenza-like illness and medication use among Pakistani pilgrims to the Haj in Saudi Arabia. Vaccine 2000, 18, 2956–2962. [Google Scholar] [CrossRef]
  96. Hoang, V.T.; Nguyen, T.T.T.; Belhouchat, K.; Meftah, M.; Sow, D.; Benkouiten, S.; Dao, T.-L.; Ly, T.D.A.; Drali, T.; Yezli, S.; et al. Antibiotic use for respiratory infections among Hajj pilgrims: A cohort survey and review of the literature. Travel Med. Infect. Dis. 2019, 30, 39–45. [Google Scholar] [CrossRef]
  97. Al-Tawfiq, J.A.; Memish, Z.A. Potential risk for drug resistance globalization at the Hajj. Clin. Microbiol. Infect. 2015, 21, 109–114. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  98. Memish, Z.A.; Al-Tawfiq, J.A.; Al-Rabeeah, A.A. Hajj: Preparations underway. Lancet Glob. Health 2013, 1. [Google Scholar] [CrossRef] [Green Version]
  99. Al-Tawfiq, J.A.; Memish, Z.A. The Hajj 2019 vaccine requirements and possible new challenges. J. Epidemiol. Glob. Health 2019, 9, 147–152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  100. Memish, Z.A.; Assiri, A.; Almasri, M.; Alhakeem, R.F.; Turkestani, A.; Al Rabeeah, A.A.; Akkad, N.; Yezli, S.; Klugman, K.; O’Brien, K.; et al. Impact of the Hajj on pneumococcal transmission. Clin. Microbiol. Infect. 2015, 21, 77.e8. [Google Scholar] [CrossRef] [Green Version]
  101. Tashani, M.; Barasheed, O.; Azeem, M.; Alfelali, M.; Badahdah, A.-M.; Bokhary, H.; Almasri, N.; AlShehri, J.; Matbouly, G.; Kalantan, N.; et al. Pneumococcal Vaccine Uptake Among Australian Hajj Pilgrims in 2011–2013. Infect. Disord. Drug Targets 2014, 14, 117–124. [Google Scholar] [CrossRef]
  102. Gautret, P.; Hai, V.V.; Sani, S.; Doutchi, M.; Parola, P.; Brouqui, P. Protective measures against acute respiratory symptoms in French pilgrims participating in the Hajj of 2009. J. Travel Med. 2010, 18, 53–55. [Google Scholar] [CrossRef]
  103. Gautret, P.; Bauge, M.; Simon, F.; Benkouiten, S.; Parola, P.; Brouqui, P. Pneumococcal vaccination and Hajj. Int. J. Infect. Dis. 2011, 15. [Google Scholar] [CrossRef] [PubMed]
  104. Benkouiten, S.; Gautret, P.; Belhouchat, K.; Drali, T.; Salez, N.; Memish, Z.A.; Al Masri, M.; Fournier, P.-E.; Brouqui, P. Acquisition of streptococcus pneumoniae carriage in pilgrims during the 2012 Hajj. Clin. Infect. Dis. 2014, 58, e106–e109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  105. Meysamie, A.; Ardakani, H.Z.; Razavi, S.M.; Doroodi, T. Comparison of mortality and morbidity rates among Iranian pilgrims in Hajj 2004 and 2005. Saudi Med. J. 2006, 27, 1049–1053. [Google Scholar]
  106. Ridda, I.; King, C.; Rashid, H. Pneumococcal Infections at Hajj: Current Knowledge Gaps. Infect. Disord. Drug Targets 2014, 14, 177–184. [Google Scholar] [CrossRef] [PubMed]
  107. Elachola, H.; Gozzer, E.; Zhuo, J.; Sow, S.; Kattan, R.; Mimesh, S.A.; Al-Tawfiq, J.A.; Al-Sultan, M.; Memish, Z.A. Mass gatherings: A one-stop opportunity to complement global disease surveillance. J. Health Spec. 2016, 4, 178. [Google Scholar] [CrossRef]
  108. Ebrahim, S.H.; Kattan, R.F.; Elambilakkat, S.; Khan, A.A.; Memish, Z.A. Religious Mass Gathering (Hajj) and Antimicrobial Resistance: From Challenges to Opportunities. Handb. Environ. Chem. 2020, 91, 295–310. [Google Scholar] [CrossRef]
  109. World Health Organization. Towards Access 2030 WHO Medicines and Health Products Programme Strategic; WHO: Geneva, Switzerland, 2016. [Google Scholar]
  110. Tamma, P.D.; Miller, M.A.; Cosgrove, S.E. Rethinking How Antibiotics Are Prescribed: Incorporating the 4 Moments of Antibiotic Decision Making into Clinical Practice. JAMA J. Am. Med. Assoc. 2019, 321, 139–140. [Google Scholar] [CrossRef] [PubMed]
  111. Kyu, H.H.; Maddison, E.R.; Henry, N.J.; Ledesma, J.R.; Wiens, K.E.; Reiner, R.; Biehl, M.H.; Shields, C.; Osgood-Zimmerman, A.; Ross, J.M.; et al. Global, regional, and national burden of tuberculosis, 1990–2016: Results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet Infect. Dis. 2018, 18, 1329–1349. [Google Scholar] [CrossRef] [Green Version]
  112. Amin, M.; Bakhtiar, A.; Subarjo, M.; Aksono, E.B.; Widiyanti, P.; Shimizu, K.; Mori, Y. Screening for Middle East respiratory syndrome coronavirus among febrile Indonesian Hajj pilgrims: A study on 28,197 returning pilgrims. J. Infect. Prev. 2018, 19, 236–239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Gautret, P.; Al-Tawfiq, J.A.; Hoang, V.T. COVID 19: Will the 2020 Hajj pilgrimage and Tokyo Olympic Games be cancelled? Travel Med. Infect. Dis. 2020, 34, 101622. [Google Scholar] [CrossRef]
  114. Al-Tawfiq, J.A.; Memish, Z.A.; Zumla, A. Mass Religious Gatherings Events and COVID-19 -Easing of COVID-19 Restrictions and a Staged Approach to Scaling up the Umrah Pilgrimage. Travel Med. Infect. Dis. 2021, 101986. [Google Scholar] [CrossRef] [PubMed]
  115. Di Gennaro, F.; Marotta, C.; Amicone, M.; Bavaro, D.F.; Bernaudo, F.; Frisicale, E.M.; Kurotschka, P.; Mazzari, A.; Veronese, N.; Murri, R.; et al. Italian young doctors’ knowledge, attitudes and practices on antibiotic use and resistance: A national cross-sectional survey. J. Glob. Antimicrob. Resist. 2020, 23, 167–173. [Google Scholar] [CrossRef]
  116. Bokhary, H.; Barasheed, O.; Khatami, A.G.M.; Hill-Cawthorne, G.A.; Rashid, H. Pilot survey of knowledge, attitudes and perceptions of Hajj deployed health care workers on antibiotics and antibiotic prescriptions for upper respiratory tract infections: Results from two Hajj seasons. Trop. Med. Infect. Dis. 2020, 5, 18. [Google Scholar] [CrossRef] [Green Version]
  117. Ahmed, Q.A.; Ebrahim, S.; Memish, Z.A. From Hajj services to Mass Gathering Medicine: Saudi Arabia formalizes a novel discipline. Travel Med. Infect. Dis. 2019, 28, 105–106. [Google Scholar] [CrossRef] [PubMed]
Tropicalmed 06 00033 g001 550
Figure 1. The number of the annual Hajj pilgrims per year 1996–2019.
Figure 1. The number of the annual Hajj pilgrims per year 1996–2019.
Tropicalmed 06 00033 g001
Table
Table 1. A Summary of the different extended-spectrum-β-lactamase (bla) genes that had been identified in the Hajj.
Table 1. A Summary of the different extended-spectrum-β-lactamase (bla) genes that had been identified in the Hajj.
GeneOrganismReference
blaCTX-M-15Salmonella spp. and E. coli[23,36,37]
blaOXA-72Acinetobacter baumannii[37]
blaNDM-5Escherichia coli[37]
blaCTX-MEscherichia coli, K. pneumoniae[35,36,37,45]
blaNDMSalmonella, enterotoxigenic E. coli, K. pneumoniae,[23,37,46]
blaOXAE. coli, K. pneumoniae, Acinetobacter baumannii[36,37,46]
blaTEME. coli, K. pneumoniae,[35,36,37]
blaSHVE. coli, K. pneumoniae,[35,36]
blaVIMK. pneumoniae[46]
aac6, aac6Ib, aadA4, strB, aadA1, aadA2, aadB, ant2, aphA, strAaminoglycoside-resistant E. coli[36]
Table
Table 2. A summary of Studies Examining Methicillin-Resistant Staphylococcus aureus in the Hajj pilgrims and workers.
Table 2. A summary of Studies Examining Methicillin-Resistant Staphylococcus aureus in the Hajj pilgrims and workers.
Study YearSourceNumber of Individuals with MRSA/No. of Individuals with Positive Culture (%)Reference
2000–2001Skin lesion1/47 (2.1)[48]
2000–2001Multiple sites0/45 (0)[52]
2004Nasal, axilla, groin and open wound swabs6/85 (7.1)[57]
2009Nasal swabs16/155 (10.3)[51]
2009Nasal swabs30/153 (19.6)[51]
2014Nasal and hand skin swabs33/165 (20.0)[53]
2014Sinus13/46 (28.3)[49]
2015Urine, blood, sputum36/57 (63.2)[50]
2003–2004Wound swabs, ear swabs, eye swabs, blood, urine, respiratory tract199/512 (38.9)[58]
2004–2005Blood161/303 (53.0)[41]
2008–2009Multiple271/688 (39.4)[54]
2011–2012Foot infection and urinary tract infection samples15/26 (57.7)[33]
2012No data100/206 (48.5) mec
19/100 (19.0) PVL		[56]
No dataBlood cultures, wound swabs, urine, nasal swabs, and sputum11/50 (22.0)[55]
Table
Table 3. A summary of studies describing active tuberculosis among Pilgrims.
Table 3. A summary of studies describing active tuberculosis among Pilgrims.
Number of Admitted PilgrimsNumber (%) with Active TuberculosisReference
303 (10)[62]
469 (20)[63]
80810 (1.2)[64]
45222 (4.9)[61]
1181 (1)[65]
106315 (1.4)[66]
Table
Table 4. Pneumococcal vaccination rates in Hajj pilgrims.
Table 4. Pneumococcal vaccination rates in Hajj pilgrims.
Year of PilgrimagePrevalence of Pneumococcal Vaccination (%)Reference
2011–201314.2–28.7[101]
200931.4[102]
20101.7[103]
201235.9[104]
201351.2[90]
2004–20052.5–8.9[105]
20055[106]
20134.4[18]
20131.4[60]
20131.2[89]
2011–201211.3[100]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Al-Tawfiq, J.A.; Memish, Z.A. The Emergence, Persistence, and Dissemination of Antimicrobial-Resistant Bacteria in Environmental Hajj Settings and Implications for Public Health. Trop. Med. Infect. Dis. 2021, 6, 33. https://0-doi-org.brum.beds.ac.uk/10.3390/tropicalmed6010033

AMA Style

Al-Tawfiq JA, Memish ZA. The Emergence, Persistence, and Dissemination of Antimicrobial-Resistant Bacteria in Environmental Hajj Settings and Implications for Public Health. Tropical Medicine and Infectious Disease. 2021; 6(1):33. https://0-doi-org.brum.beds.ac.uk/10.3390/tropicalmed6010033

Chicago/Turabian Style

Al-Tawfiq, Jaffar A., and Ziad A. Memish. 2021. "The Emergence, Persistence, and Dissemination of Antimicrobial-Resistant Bacteria in Environmental Hajj Settings and Implications for Public Health" Tropical Medicine and Infectious Disease 6, no. 1: 33. https://0-doi-org.brum.beds.ac.uk/10.3390/tropicalmed6010033

Article Metrics

Back to TopTop